Role of oral teriflunomide in the management of multiple sclerosis
Radu Tanasescu,1,2 Nikos Evangelou,1 Cris S Constantinescu1 1Academic Division of Clinical Neurology, University of Nottingham, Nottingham, UK; 2Department of Neurology, Colentina Hospital, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania Abstract: The landscape of the treatment...
Enregistré dans:
Auteurs principaux: | Tanasescu R, Evangelou N, Constantinescu CS |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/80d40c8d91304dd493f0e94de2b27fd1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Review of teriflunomide and its potential in the treatment of multiple sclerosis
par: Clemens Warnke, et autres
Publié: (2009) -
Cannabinoids in the management of spasticity associated with multiple sclerosis
par: Anna Maria Malfitano, et autres
Publié: (2008) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
par: Warnke C, et autres
Publié: (2011) -
The role of glatiramer acetate in the early treatment of multiple sclerosis
par: David W Brandes
Publié: (2010) -
Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis
par: Julie A Murphy, et autres
Publié: (2010)